Thermo Fisher Scientific Inc.
TMO · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $6,338 | $5,995 | $6,960 | $7,728 |
| Dep. & Amort. | $3,108 | $3,406 | $3,381 | $2,592 |
| Deferred Tax | -$1,209 | -$1,300 | -$995 | -$406 |
| Stock-Based Comp. | $301 | $278 | $307 | $230 |
| Change in WC | -$334 | -$537 | -$1,049 | -$1,558 |
| Other Non-Cash | $463 | $564 | $550 | $957 |
| Operating Cash Flow | $8,667 | $8,406 | $9,154 | $9,543 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,400 | -$1,479 | -$2,243 | -$2,523 |
| Net Acquisitions | -$3,132 | -$3,660 | -$39 | -$19,395 |
| Inv. Purchases | -$3,396 | $0 | -$15 | -$8 |
| Inv. Sales/Matur. | $1,770 | $70 | $15 | $8 |
| Other Inv. Act. | $317 | -$73 | $123 | -$14 |
| Investing Cash Flow | -$5,841 | -$5,142 | -$2,159 | -$21,932 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$2,403 | -$155 | $654 | $8,911 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$4,000 | -$3,000 | -$3,000 | -$2,000 |
| Dividends Paid | -$583 | -$523 | -$455 | -$395 |
| Other Fin. Act. | $194 | $56 | -$9 | $65 |
| Financing Cash Flow | -$6,792 | -$3,622 | -$2,810 | $6,581 |
| Forex Effect | -$91 | -$82 | -$139 | -$37 |
| Net Chg. in Cash | -$4,057 | -$440 | $4,046 | -$5,845 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $8,097 | $8,537 | $4,491 | $10,336 |
| End Cash | $4,040 | $8,097 | $8,537 | $4,491 |
| Free Cash Flow | $7,267 | $6,927 | $6,911 | $7,020 |